Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Br J Pharmacol. 2001 Jan;132(2):381-4.

    Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells.

    Source

    ICAgen Inc., 4222 Emperor Boulevard, Durham, North Carolina, NC 27703, USA. awickenden@icagen.com

    Abstract

    Heteromeric KCNQ5/Q3 channels were stably expressed in Chinese Hamster ovary cells and characterized using the whole cell voltage-clamp technique. KCNQ5/Q3 channels were activated by the novel anticonvulsant, retigabine (EC(50) 1.4 microM) by a mechanism that involved drug-induced, leftward shifts in the voltage-dependence of channel activation (-31.8 mV by 30 microM retigabine). KCNQ5/Q3 channels were inhibited by linopirdine (IC(50) 7.7 microM) and barium (IC(50) 0.46 mM), at concentrations similar to those required to inhibit native M-currents. These findings identify KCNQ5/Q3 channels as a molecular target for retigabine and raise the possibility that activation of KCNQ5/Q3 channels may be responsible for some of the anti-convulsant activity of this agent. Furthermore, the sensitivity of KCNQ5/Q3 channels to linopirdine supports the possibility that potassium channels comprised of KCNQ5 and KCNQ3 may make a contribution to native M-currents.

    PMID:
    11159685
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1572592
    Free PMC Article

    Images from this publication.See all images (2)Free text

    Figure 1
    Figure 2

      Supplemental Content

      Icon for Blackwell Publishing Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk